Transcriptome-Guided Drug Repurposing for Aggressive SCCs

Transcriptome-Guided Drug Repurposing for Aggressive SCCs

Despite a significant rise in the incidence of cutaneous squamous cell carcinoma (SCC) in recent years, most SCCs are well treatable. However, against the background of pre-existing risk factors such as immunosuppression upon organ transplantation, or conditions such as recessive dystrophic epidermo...

Full description

Bibliographic Details
Main Authors: Roland Zauner, Monika Wimmer, Sonja Dorfer, Michael Ablinger, Ulrich Koller, Josefina Piñón Hofbauer, Christina Guttmann-Gruber, Johann W. Bauer, Verena Wally
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
epidermolysis bullosa
organ transplant recipients
squamous cell carcinoma
drug repurposing
Online Access:https://www.mdpi.com/1422-0067/23/2/1007

Internet

https://www.mdpi.com/1422-0067/23/2/1007

Similar Items